Company Description

Amathus Therapeutics is a biopharmaceutical company and leader in the field of small molecule modulators of organelle specific chaperones across a variety of genetically defined diseases including Parkinsonﾒs Disease (PINK1) and Polycystic Kidney Disease (ADPKD).